Daniel Menold

Insider Reports History

Entity
Individual
Location
C/O Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark, CA
Signature
/s/ Paul Quinlan, as attorney-in-fact for Daniel Menold
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Menold:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CymaBay Therapeutics, Inc. Vice President, Finance Employee Stock Option (right to buy) 135K Jan 16, 2024 Direct
CymaBay Therapeutics, Inc. Vice President, Finance Common Stock 0 $23.68 Jan 16, 2024 Direct

Insider Reports Filed by Daniel Menold

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CBAY CymaBay Therapeutics, Inc. Jan 16, 2024 3 -$195K 4 Jan 16, 2024 Vice President, Finance
CBAY CymaBay Therapeutics, Inc. Dec 15, 2023 6 -$335K 4 Dec 15, 2023 Vice President, Finance
CBAY CymaBay Therapeutics, Inc. Nov 15, 2023 3 $60.4K 4 Nov 17, 2023 Vice President, Finance
CBAY CymaBay Therapeutics, Inc. Oct 16, 2023 3 $60.4K 4 Oct 18, 2023 Vice President, Finance
CBAY CymaBay Therapeutics, Inc. Sep 15, 2023 6 $28.6K 4 Sep 19, 2023 Vice President, Finance
CBAY CymaBay Therapeutics, Inc. Aug 15, 2023 6 $79K 4 Aug 16, 2023 Vice President, Finance
CBAY CymaBay Therapeutics, Inc. Aug 9, 2023 4 -$154K 4 Aug 11, 2023 Vice President, Finance
CBAY CymaBay Therapeutics, Inc. Jan 25, 2023 1 $0 4 Jan 27, 2023 Vice President, Finance
CBAY CymaBay Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 Vice President, Finance